ABBV Jan 2025 130.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:14PM EDT. Market open.
| Previous close | 41.15 |
| Open | 41.15 |
| Bid | 39.60 |
| Ask | 41.45 |
| Strike | 130.00 |
| Expiry date | 2025-01-17 |
| Day's range | 41.15 - 41.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 377 |
Investor's Business DailyThe Bad News Heading Into AbbVie's First-Quarter Earnings Report
AbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.
ZacksEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksPharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
© 2024 Yahoo. All rights reserved.